Individuals must be symptomatic with respiratory symptoms
Individuals must complete the UCAP-Q questionnaire and score a ≥ 6% probability of having either asthma or COPD.
Individuals who have given written informed consent to participate in this trial in accordance with local regulations;
Individual must be able to perform pre and post bronchodilator spirometry to measure lung function
Individuals who have undiagnosed airflow obstruction on spirometry testing (i.e. Asthma or COPD) will be asked to participate in the RCT.
You may not be if
Individuals who report a previous diagnosis of asthma, COPD, history of lung cancer, bronchiectasis, interstitial lung disease, cystic fibrosis or other significant diagnosed lung disease.
Individuals currently under the care of a Respirologist.
Individuals currently using inhaled corticosteroids or long-acting bronchodilators.
Individuals with history of myocardial infarction, stroke, aortic or cerebral aneurysm, or detached retina or eye surgery within the past 3 months (spirometry is contraindicated)
Individuals who are in the third trimester of pregnancy
Individuals involved in another interventional trial
Clareo Health | Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL
